Cargando…

Acute Toxic Effects of the New Psychoactive Substance “Voodoo” among Patients presented to the Poison Control Center of Ain Shams University Hospitals (PCC-ASUH), Egypt, during 2017

BACKGROUND: Voodoo is a heterogeneous mixture of psychoactive substances that has recently grown in popularity among youth in Egypt. Patients can present with a variety of manifestations that may lead to death in some cases. This study assessed the acute toxic effects of voodoo among patients presen...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussien, Rania, El-Setouhy, Maged, Shinawi, Mohamed El, El-Hariri, Hazem Mohamed, Hirshon, Jon Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454133/
https://www.ncbi.nlm.nih.gov/pubmed/34544462
http://dx.doi.org/10.1186/s13011-021-00408-4
_version_ 1784570427054489600
author Hussien, Rania
El-Setouhy, Maged
Shinawi, Mohamed El
El-Hariri, Hazem Mohamed
Hirshon, Jon Mark
author_facet Hussien, Rania
El-Setouhy, Maged
Shinawi, Mohamed El
El-Hariri, Hazem Mohamed
Hirshon, Jon Mark
author_sort Hussien, Rania
collection PubMed
description BACKGROUND: Voodoo is a heterogeneous mixture of psychoactive substances that has recently grown in popularity among youth in Egypt. Patients can present with a variety of manifestations that may lead to death in some cases. This study assessed the acute toxic effects of voodoo among patients presented to the Poison Control Center of Ain Shams University Hospitals (PCC-ASUH) during a one year period. METHODS: This is a retrospective study of all patients presented with voodoo intoxication at the PCC-ASUH from 1 January 2017 to 31 December 2017. Clinical data, routine laboratory findings, and ECG results as well as duration of hospitalization and outcome were compiled from hospital records. RESULTS: Seventy-one voodoo intoxication cases meeting the inclusion criteria were analyzed (mean age: 25.19 ± 9.54 years, range: 15–50 years, 97.2 % male). Pulse, blood pressure, and respiratory rate were normal in more than half of all patients. Neurological abnormalities including agitation, hallucinations, disturbance of consciousness were the most frequent manifestations. Respiratory acidosis was the most common laboratory finding (54.9 %), followed by increased serum urea (43.6 %), hypokalemia (33.8 %), hyperglycemia (28.1 %), and leukocytosis (26.7 %). The most common ECG finding was sinus tachycardia (31 %), followed by QT prolongation (15.4 %). More than half of the studied patients (53.5 %) co-administered other illicit substances, most frequently cannabis and tramadol. Most patients recovered fully and were discharged, but death occurred in two cases. CONCLUSIONS: Voodoo toxicity can manifest with many presentations, hampering timely diagnosis. Clinicians should consider possible voodoo poisoning in patients presenting with a history of drug use with neurological symptoms, and they should conduct follow-up arterial blood gases, electrolytes and ECG as voodoo may contain potentially fatal psychoactive substances.
format Online
Article
Text
id pubmed-8454133
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-84541332021-09-21 Acute Toxic Effects of the New Psychoactive Substance “Voodoo” among Patients presented to the Poison Control Center of Ain Shams University Hospitals (PCC-ASUH), Egypt, during 2017 Hussien, Rania El-Setouhy, Maged Shinawi, Mohamed El El-Hariri, Hazem Mohamed Hirshon, Jon Mark Subst Abuse Treat Prev Policy Research BACKGROUND: Voodoo is a heterogeneous mixture of psychoactive substances that has recently grown in popularity among youth in Egypt. Patients can present with a variety of manifestations that may lead to death in some cases. This study assessed the acute toxic effects of voodoo among patients presented to the Poison Control Center of Ain Shams University Hospitals (PCC-ASUH) during a one year period. METHODS: This is a retrospective study of all patients presented with voodoo intoxication at the PCC-ASUH from 1 January 2017 to 31 December 2017. Clinical data, routine laboratory findings, and ECG results as well as duration of hospitalization and outcome were compiled from hospital records. RESULTS: Seventy-one voodoo intoxication cases meeting the inclusion criteria were analyzed (mean age: 25.19 ± 9.54 years, range: 15–50 years, 97.2 % male). Pulse, blood pressure, and respiratory rate were normal in more than half of all patients. Neurological abnormalities including agitation, hallucinations, disturbance of consciousness were the most frequent manifestations. Respiratory acidosis was the most common laboratory finding (54.9 %), followed by increased serum urea (43.6 %), hypokalemia (33.8 %), hyperglycemia (28.1 %), and leukocytosis (26.7 %). The most common ECG finding was sinus tachycardia (31 %), followed by QT prolongation (15.4 %). More than half of the studied patients (53.5 %) co-administered other illicit substances, most frequently cannabis and tramadol. Most patients recovered fully and were discharged, but death occurred in two cases. CONCLUSIONS: Voodoo toxicity can manifest with many presentations, hampering timely diagnosis. Clinicians should consider possible voodoo poisoning in patients presenting with a history of drug use with neurological symptoms, and they should conduct follow-up arterial blood gases, electrolytes and ECG as voodoo may contain potentially fatal psychoactive substances. BioMed Central 2021-09-20 /pmc/articles/PMC8454133/ /pubmed/34544462 http://dx.doi.org/10.1186/s13011-021-00408-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Hussien, Rania
El-Setouhy, Maged
Shinawi, Mohamed El
El-Hariri, Hazem Mohamed
Hirshon, Jon Mark
Acute Toxic Effects of the New Psychoactive Substance “Voodoo” among Patients presented to the Poison Control Center of Ain Shams University Hospitals (PCC-ASUH), Egypt, during 2017
title Acute Toxic Effects of the New Psychoactive Substance “Voodoo” among Patients presented to the Poison Control Center of Ain Shams University Hospitals (PCC-ASUH), Egypt, during 2017
title_full Acute Toxic Effects of the New Psychoactive Substance “Voodoo” among Patients presented to the Poison Control Center of Ain Shams University Hospitals (PCC-ASUH), Egypt, during 2017
title_fullStr Acute Toxic Effects of the New Psychoactive Substance “Voodoo” among Patients presented to the Poison Control Center of Ain Shams University Hospitals (PCC-ASUH), Egypt, during 2017
title_full_unstemmed Acute Toxic Effects of the New Psychoactive Substance “Voodoo” among Patients presented to the Poison Control Center of Ain Shams University Hospitals (PCC-ASUH), Egypt, during 2017
title_short Acute Toxic Effects of the New Psychoactive Substance “Voodoo” among Patients presented to the Poison Control Center of Ain Shams University Hospitals (PCC-ASUH), Egypt, during 2017
title_sort acute toxic effects of the new psychoactive substance “voodoo” among patients presented to the poison control center of ain shams university hospitals (pcc-asuh), egypt, during 2017
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454133/
https://www.ncbi.nlm.nih.gov/pubmed/34544462
http://dx.doi.org/10.1186/s13011-021-00408-4
work_keys_str_mv AT hussienrania acutetoxiceffectsofthenewpsychoactivesubstancevoodooamongpatientspresentedtothepoisoncontrolcenterofainshamsuniversityhospitalspccasuhegyptduring2017
AT elsetouhymaged acutetoxiceffectsofthenewpsychoactivesubstancevoodooamongpatientspresentedtothepoisoncontrolcenterofainshamsuniversityhospitalspccasuhegyptduring2017
AT shinawimohamedel acutetoxiceffectsofthenewpsychoactivesubstancevoodooamongpatientspresentedtothepoisoncontrolcenterofainshamsuniversityhospitalspccasuhegyptduring2017
AT elharirihazemmohamed acutetoxiceffectsofthenewpsychoactivesubstancevoodooamongpatientspresentedtothepoisoncontrolcenterofainshamsuniversityhospitalspccasuhegyptduring2017
AT hirshonjonmark acutetoxiceffectsofthenewpsychoactivesubstancevoodooamongpatientspresentedtothepoisoncontrolcenterofainshamsuniversityhospitalspccasuhegyptduring2017